Inmune Bio INMB
NASDAQ INMB
$1.54 -0.07 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inmune Bio (INMB) Change in Other Operating Assets (2018 - 2026)

Updated

Analysis

Inmune Bio (INMB) Change in Other Operating Assets (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,140.91 Bn 1,109.50 Bn 19.71 Bn -
2 Johnson & Johnson 634.46 Bn 554.32 Bn 17.30 Bn -122.00 Mn
3 AbbVie 500.42 Bn 473.54 Bn 12.70 Bn 188.00 Mn
4 Merck 355.19 Bn 309.56 Bn 12.21 Bn -
5 Novartis Ag 300.18 Bn 264.17 Bn 11.24 Bn -
6 Astrazeneca 263.17 Bn 236.86 Bn 12.86 Bn -
7 Amgen 237.83 Bn 193.23 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 193.81 Bn 168.01 Bn 6.22 Bn 13.00 Mn
9 Pfizer 170.12 Bn 116.76 Bn 10.94 Bn -
10 Inmune Bio 39.14 Mn -53.11 Mn - -156,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -156,000.00
Mar 31, 2026 221,000.00
Dec 31, 2025 -531,000.00
Sep 30, 2025 353,000.00
Jun 30, 2025 1.24 Mn
Mar 31, 2025 -249,000.00
Dec 31, 2024 -634,000.00
Sep 30, 2024 -92,000.00
Jun 30, 2024 -431,000.00
Mar 31, 2024 -525,000.00
Dec 31, 2023 480,000.00
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -1.15 Mn
Mar 31, 2023 -393,000.00
Dec 31, 2022 -184,000.00
Sep 30, 2022 429,000.00
Jun 30, 2022 -774,000.00
Mar 31, 2022 2.30 Mn
Dec 31, 2021 1.38 Mn
Sep 30, 2021 140,000.00
API Access

Inmune Bio Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=INMB&period=max&api_key=YOUR_API_KEY